Credit Suisse’s SkinHealth Systems SKIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-157,268
Closed -$489K 3026
2023
Q4
$489K Sell
157,268
-509,819
-76% -$1.91M ﹤0.01% 2742
2023
Q3
$4.02M Sell
667,087
-4,602
-0.7% -$32.3K ﹤0.01% 1389
2023
Q2
$5.62M Sell
671,689
-141,777
-17% -$1.47M 0.01% 1263
2023
Q1
$10.3M Buy
813,466
+132,856
+20% +$1.54M 0.01% 927
2022
Q4
$6.19M Sell
680,610
-90,222
-12% -$974K 0.01% 1174
2022
Q3
$9.09M Sell
770,832
-18,062
-2% -$228K 0.01% 958
2022
Q2
$10.1M Sell
788,894
-37,990
-5% -$509K 0.01% 934
2022
Q1
$14M Buy
826,884
+31,423
+4% +$519K 0.01% 898
2021
Q4
$19.2M Buy
+795,461
New +$20.5M 0.01% 1108

Other funds holding SKIN

Credit Suisse's SKIN Position: Q1 2024 in Review

Credit Suisse sold out of SkinHealth Systems (SKIN) in Q1 2024, closing a stake of 157,268 shares — an estimated $489K sold.

Credit Suisse first reported a position in SKIN in Q4 2021 and held it in 9 quarters. The position peaked at $19.2M in Q4 2021. 120 funds tracked by Wall St. Rank hold SKIN as of Q1 2024.

  • Credit Suisse reported no remaining SkinHealth Systems position as of Q1 2024 after selling out during the quarter.
  • Credit Suisse sold 157,268 SkinHealth Systems shares in Q1 2024, an estimated $489K.
  • Credit Suisse first reported a position in SkinHealth Systems in Q4 2021 and held it in 9 quarters.
  • Credit Suisse's SkinHealth Systems position peaked at $19.2M in Q4 2021.
  • 120 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.